Rapamycin May Be Potential Treatment for Kidney Disease, University of California, Santa Barbara Study
(Santa Barbara, Calif.) –– Research performed at UC Santa Barbara points to the drug rapamycin as a potential treatment for kidney disease. The study builds on past research and shows that studies performed on mice are more likely to translate to humans than previously thought. The results are published in the current online issue of the Journal of the American Society of Nephrology.